Taking the Long View in the Treatment of CLL

Kerry A. Rogers, MD

Disclosures

May 30, 2023

Kerry A. Rogers, MD, accents the "chronic" aspect of chronic lymphocytic leukemia (CLL) and how patients are affected by the way specific treatments blend with the circumstances of their lives.

Summing up the advances made over recent decades, Dr Rogers notes how treatment extended over time reveals a range of response, in that patients previously without good options might benefit from more novel therapies, often in the context of clinical trials.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....